Mazdutide
An investigational GLP-1/glucagon dual agonist showing promising weight loss in clinical trials.
Patient-Friendly Explanation
Mazdutide is an investigational medication that works on two gut hormones — GLP-1 and glucagon — to reduce appetite and help the body burn more energy. It is currently in clinical trials and has shown promising weight loss results.
Clinical Definition
Mazdutide is a unimolecular dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors. By co-activating GLP-1R (appetite suppression, delayed gastric emptying) and GCGR (increased energy expenditure, lipolysis, hepatic fat oxidation), it targets both energy intake and expenditure — a dual mechanism that may produce superior weight loss compared to GLP-1 mono-agonists.
Why It Matters
Dual and triple agonists represent the next generation of obesity pharmacotherapy. Dr. Joseph Wang stays current with emerging treatments to offer patients at NuLifeCare Singapore the most appropriate, evidence-based options.
This library is for general education and does not replace individual assessment by a qualified healthcare professional. Always consult a doctor for medical advice, diagnosis, or treatment.
Ready to Start Your Journey?
Book a Free Weight Management Consultation with our doctor today.
Book Free Consultation →